Careers  |  Sign In  |  Register

Latest in Endocrinology

Reuters Health • The Doctor's Channel Daily Newscast

Capillary blood glucose test beats HbA1c for mass diabetes screening

NEW YORK (Reuters Health) - As a mass screening tool for diabetes and pre-diabetes in China, the fasting capillary blood glucose (FCG) test performs better than the hemoglobin A1C (HbA1c) test, a study suggests. "We have evaluated the performance of HbA1c as a mass screening test for diabetes and...

Reuters Health • The Doctor's Channel Daily Newscast

Heart failure benefits vary among different statins

NEW YORK (Reuters Health) - The benefits of statins are variable and depend on the agent being taken, a meta-analysis has shown. Pooled data from 10 randomized trials also suggested that in general, statins don't reduce mortality but do improve left ventricular function and reduce heart failure...

Reuters Health • The Doctor's Channel Daily Newscast

Pravastatin protects against heart disease in blacks

NEW YORK (Reuters Health) – The cholesterol-lowering drug pravastatin prevents coronary heart disease in blacks, according to trial results published in the December American Heart Journal. “It's very important to manage risk factors, including hypercholesterolemia, in black patients at risk for...